Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance upgrade on Thursday 4th of May 2017 from 8.00am to 9.00am (BST).

During this time our websites will be offline temporarily. If you have any questions please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 6, 2013
Previous Article Next Article

Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation

Author affiliations

Abstract

Formyl Peptide Receptors (FPRs) are vital in the host inflammatory response, playing an important regulatory role in multiple diseases. A Gd(III) DOTA conjugate of cFLFLFK has been synthesised which targets and visualises FPR1 upon leukocytes in the inflammatory response via magnetic resonance imaging for the first time.

Graphical abstract: Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation

Back to tab navigation
Please wait while Download options loads

Supplementary files

Publication details

The article was received on 12 Oct 2012, accepted on 26 Nov 2012 and first published on 27 Nov 2012


Article type: Communication
DOI: 10.1039/C2CC37460A
Citation: Chem. Commun., 2013,49, 564-566
  •   Request permissions

    Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation

    G. J. Stasiuk, H. Smith, M. Wylezinska-Arridge, J. L. Tremoleda, W. Trigg, S. K. Luthra, V. M. Iveson, F. N. E. Gavins and N. J. Long, Chem. Commun., 2013, 49, 564
    DOI: 10.1039/C2CC37460A

Search articles by author